Assembly Biosciences ASMB
NASDAQ ASMB
$19.75 -0.53 (-2.61%)
As of: Oct 23, 2026 · 3:13 PM EDT

Assembly Biosciences (ASMB) Long-Term Debt Repayments (2011)

Updated

Assembly Biosciences (ASMB) reported Long-Term Debt Repayments of -$1.99 million for Q4 2011.

Analysis

Assembly Biosciences (ASMB) Long-Term Debt Repayments (2011) Analysis & Trends

For FY2011, Assembly Biosciences posted Long-Term Debt Repayments of $800,000.

  • Per Business Quant data, the three quarters before Q4 2011 came in at $1.57 million (Q3 2011), $419,380 (Q2 2011) and $800,000 (Q1 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,130.05 Bn 1,098.63 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 635.34 Bn 555.20 Bn 17.30 Bn 1.00 Mn
3 AbbVie 504.85 Bn 477.96 Bn 12.70 Bn 2.00 Bn
4 Merck 358.37 Bn 312.75 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 290.48 Bn 254.47 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 265.13 Bn 238.81 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.92 Bn 193.32 Bn 7.24 Bn -
8 Gilead Sciences 194.98 Bn 169.17 Bn 6.22 Bn 17.00 Mn
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn -
10 Assembly Biosciences 372.36 Mn -655.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 -1.99 Mn
Sep 30, 2011 1.57 Mn
Jun 30, 2011 419,380.00
Mar 31, 2011 800,000.00
API Access

Assembly Biosciences Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ASMB&period=max&api_key=YOUR_API_KEY